Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

Merck Shareholders See Big Changes from Acumen and Other Hedge Funds

Guavy AI Editorial Team
Instruments
MRK
Share

Acumen Wealth Advisors LLC, an institutional investor, has reduced its position in Merck & Co., Inc. (NYSE:MRK) by 70.9% in the second quarter, according to the company's latest 13F filing with the Securities and Exchange Commission.

The firm owned 7,919 shares of the pharmaceutical company after selling 19,307 shares during the period. The value of these holdings at the end of the most recent quarter was $1,024,000.

This is not an isolated case, as several other hedge funds have made changes to their positions in Merck & Co., Inc. During the fourth quarter, Brighton Jones LLC boosted its position by 29.5% and now owns 38,278 shares valued at $3,808,000.

More on Stocks

Stocks 51m ago

Bank of NYMellon Acquires Large Stake in Walt Disney

Stocks 51m ago

B. Metzler Sells 10% of Amgen Holdings Amid Hedge Fund Shift

Stocks 51m ago

Bank of New York Mellon Corp Sells Stake in Amgen Amid Analyst Optimism

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy